8-K current report · filed Nov 2, 2026

ACCENDRA HEALTH INC/VA/ (ACH) 8-K Current Report: November 2, 2026

Item 1.01Item 7.01Item EX-99.1ACH overview

Short answer

ACCENDRA HEALTH INC/VA/ (ACH) filed an 8-K current report with the SEC on November 2, 2026 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Receivables securitization extended through October 2029, preserving a longer-term funding source for working capital.

ACCENDRA HEALTH INC/VA/ 8-K event analysis

AI summary of each reported item and its exhibits

Item 1.01 · Entry into a Material Definitive Agreement

  • Receivables securitization extended through October 2029, preserving a longer-term funding source for working capital
  • Revised account-control provisions and reporting obligations, potentially increasing administrative and compliance requirements
  • PNC remains administrative and structuring agent, indicating continued banking support for the program
  • Amendment supports liquidity flexibility but does not disclose changes to borrowing capacity, pricing, or outstanding obligations

Item 7.01 · Regulation FD Disclosure

  • Press release issued November 2, 2026, covering the foregoing company event
  • Exhibit 99.1 contains the substantive disclosure and is the key investor document

Item EX-99.1 · Exhibit EX-99.1

  • $150 million receivables sale program extended to October 2029
  • Facility size unchanged, preserving an existing liquidity source
  • Extension indicates continued banking-partner support for Accendra’s receivables portfolio
  • Amendment executed October 29, 2026, extending financing availability by three years

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other ACCENDRA HEALTH INC/VA/ 8-K filings

Get the next ACH 8-K as it lands

Follow ACH for push alerts, or ask the research agent what this filing means.